Grantham, Mayo, Van Otterloo & Co (GMO)’s Ares Commercial Real Estate ACRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-71,200
Closed -$651K 797
2020
Q3
$651K Sell
71,200
-4,100
-5% -$38.4K ﹤0.01% 589
2020
Q2
$687K Buy
75,300
+42,600
+130% +$332K 0.01% 590
2020
Q1
$229K Buy
32,700
+19,900
+155% +$282K ﹤0.01% 690
2019
Q4
$203K Sell
12,800
-143,100
-92% -$2.22M ﹤0.01% 654
2019
Q3
$2.37M Sell
155,900
-30,100
-16% -$459K 0.02% 397
2019
Q2
$2.76M Buy
186,000
+26,000
+16% +$393K 0.02% 396
2019
Q1
$2.43M Buy
+160,000
New +$2.33M 0.02% 372
2017
Q1
Sell
-11,616
Closed -$159K 573
2016
Q4
$159K Sell
11,616
-5,313
-31% -$70.6K ﹤0.01% 477
2016
Q3
$213K Sell
16,929
-35,492
-68% -$447K ﹤0.01% 468
2016
Q2
$644K Buy
52,421
+32,621
+165% +$385K ﹤0.01% 450
2016
Q1
$217K Buy
+19,800
New +$206K ﹤0.01% 545

Other funds holding ACRE

Grantham, Mayo, Van Otterloo & Co (GMO)'s ACRE Position: Q4 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Ares Commercial Real Estate (ACRE) in Q4 2020, closing a stake of 71,200 shares — an estimated $651K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACRE in Q1 2016 and held it in 11 quarters. The position peaked at $2.76M in Q2 2019. 122 funds tracked by Wall St. Rank hold ACRE as of Q4 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Ares Commercial Real Estate position as of Q4 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 71,200 Ares Commercial Real Estate shares in Q4 2020, an estimated $651K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ares Commercial Real Estate in Q1 2016 and held it in 11 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Ares Commercial Real Estate position peaked at $2.76M in Q2 2019.
  • 122 funds tracked by Wall St. Rank held Ares Commercial Real Estate as of Q4 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.